A number of other equities research analysts have also commented on OFIX. BidaskClub upgraded shares of Orthofix International from a hold rating to a buy rating in a report on Friday, March 16th. Gabelli restated a buy rating on shares of Orthofix International in a report on Wednesday, February 28th. ValuEngine upgraded shares of Orthofix International from a hold rating to a buy rating in a report on Thursday, March 1st. Finally, SunTrust Banks raised their price objective on shares of Orthofix International to $67.00 and gave the stock a buy rating in a report on Monday, March 5th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. The company currently has a consensus rating of Buy and a consensus target price of $57.42.
Shares of Orthofix International (NASDAQ:OFIX) opened at $58.58 on Tuesday. The firm has a market cap of $1,092.89, a price-to-earnings ratio of 179.73, a price-to-earnings-growth ratio of 3.34 and a beta of 0.24. Orthofix International has a twelve month low of $36.10 and a twelve month high of $61.00.
Several large investors have recently modified their holdings of OFIX. Ramsey Quantitative Systems acquired a new stake in shares of Orthofix International during the fourth quarter worth $247,000. Crossmark Global Holdings Inc. acquired a new stake in Orthofix International in the 4th quarter valued at $260,000. FineMark National Bank & Trust acquired a new stake in Orthofix International in the 4th quarter valued at $266,000. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in Orthofix International in the 3rd quarter valued at $315,000. Finally, Municipal Employees Retirement System of Michigan increased its stake in Orthofix International by 60.8% in the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 6,770 shares of the medical device company’s stock valued at $320,000 after buying an additional 2,560 shares during the last quarter. Institutional investors and hedge funds own 94.74% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Orthofix International (OFIX) Upgraded to “B” by TheStreet” was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.themarketsdaily.com/2018/03/23/orthofix-international-ofix-upgraded-to-b-by-thestreet.html.
About Orthofix International
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.